New IPOs in December : ALKEM LABORATORIES & LAL PATH LABS

Dear All,
This is my first post. It is very nice to be a part of this forum with so much extensive discussions and logical explanations by our members, seniors.
This are my interpretation of the upcoming IPOs. IPOs have lost their charm and the general perception is to better buy in secondary market rather than investing in IPOs.( correct me if i am wrong)

The 2 new IPOs in the healthcare sector from DEC 8th namely ALKEM LABORATORIES ( pharma ) and LAL PATH LABS are being released in a very high price band which they dont deserve.

Drawbacks;

ALKEM LABORATORIES ( pharma ) :

1. Price band of 1020 -1050 is too very high . 300 – 315 should have been in a comfortable zone to invest.

2. Inspite of being issued at a higher priceband , the facevalue of each share is only Rs 2/- and not Rs 10/-.

LAL PATH LABS:

1. Priceband of 540-550 seems high

2. The money being raised by IPO is being used to relieve the promoters and investors and not for company use or expansion

Kindly add / give suggestions.